Zura Change In Cash from 2010 to 2026
| ZURA Stock | 6.21 0.05 0.80% |
Change In Cash | First Reported 2010-12-31 | Previous Quarter 88.2 M | Current Value 48.7 M | Quarterly Volatility 35 M |
Check Zura Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zura Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.7 K, Other Operating Expenses of 40.2 M or Total Operating Expenses of 40.2 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.21. Zura financial statements analysis is a perfect complement when working with Zura Bio Valuation or Volatility modules.
Zura | Change In Cash | Build AI portfolio with Zura Stock |
Analyzing Zura Bio's Change In Cash over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Change In Cash has evolved provides context for assessing Zura Bio's current valuation and future prospects.
Latest Zura Bio's Change In Cash Growth Pattern
Below is the plot of the Change In Cash of Zura Bio Limited over the last few years. It is Zura Bio's Change In Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Zura Bio's overall financial position and show how it may be relating to other accounts over time.
| Change In Cash | 10 Years Trend |
|
Change In Cash |
| Timeline |
Zura Change In Cash Regression Statistics
| Arithmetic Mean | 18,951,880 | |
| Geometric Mean | 2,272,245 | |
| Coefficient Of Variation | 184.63 | |
| Mean Deviation | 27,771,384 | |
| Median | 729,223 | |
| Standard Deviation | 34,990,435 | |
| Sample Variance | 1224.3T | |
| Range | 97.5M | |
| R-Value | 0.69 | |
| Mean Square Error | 689.1T | |
| R-Squared | 0.47 | |
| Significance | 0 | |
| Slope | 4,762,276 | |
| Total Sum of Squares | 19589.3T |
Zura Change In Cash History
About Zura Bio Financial Statements
Zura Bio stakeholders use historical fundamental indicators, such as Zura Bio's Change In Cash, to determine how well the company is positioned to perform in the future. Although Zura Bio investors may analyze each financial statement separately, they are all interrelated. For example, changes in Zura Bio's assets and liabilities are reflected in the revenues and expenses on Zura Bio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Zura Bio Limited. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Change In Cash | 88.2 M | 48.7 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Zura Bio Limited offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zura Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zura Bio Limited Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zura Bio Limited Stock:Check out the analysis of Zura Bio Correlation against competitors. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zura Bio. Anticipated expansion of Zura directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Zura Bio assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Zura Bio Limited requires distinguishing between market price and book value, where the latter reflects Zura's accounting equity. The concept of intrinsic value - what Zura Bio's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Zura Bio's price substantially above or below its fundamental value.
Please note, there is a significant difference between Zura Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zura Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Zura Bio's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.